TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06303232

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MANUAL LYMPHATIC DRAINAGE
Description: MLD was performed after the moist heating of 10 minutes in supine position with both knees bent. It will start from the abdominal lymph drainage followed by the central lymph drainage.~Then, by stimulating the bilateral axillary lymph nodes, the flow of the fluid was directed to the axillary lymph node. Each session lasted for approximately 45 minutes, for 7 days

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: THERAPEUTIC ULTRASOUND
Description: The participants of group B will receive a treatment of manual lymphatic drainage and ultrasound after the moist heat of 10 minutes. After MLD of 45 minutes, ultrasound will be performed in small circular pattern from periphery to the center towards the areola with following parameters: Mode: pulsed, Frequency: 1MHz, Intensity: 1W/cm2, Time: 8 minutes. Treatment was given for 7 consecutive days
Study: NCT05989958

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: HepaCure
Description: HepaCure will be administered in extracorporal dialysis for single dose or multiple doses with different treatment duration on top of DPMAS.
Study: NCT06564896

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CPAP Airsense 10 vs Air-Mini
Description: Patients' satisfaction and CPAP efficacy

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CPAP Airsense 10 vs Air-Mini
Description: Patients' satisfaction and CPAP efficacy
Study: NCT04886700

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SG001
Description: Subjects will receive intravenous infusion of SG001 at the dose of 240 mg every 2 weeks until disease progression, unacceptable toxicity, meeting the suspension or termination criteria, or up to 24 months in patients without disease progression.
Study: NCT04809259

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Isothermal pouch
Description: The study will verify it the use of an isothermal pouch to maintain the content of an elastomeric pump at 10° to 15°C avoids unacceptable meropenem degradation over the 24 hour infusion period.
Study: NCT05845463

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cerebro endoscopy quality control tool
Description: The AI provides feedback via a separate screen to the endoscopists to inform them which part of the upper GI tract have been adequately visualised.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cerebro endoscopy quality control tool
Description: The AI provides feedback via a separate screen to the endoscopists to inform them which part of the upper GI tract have been adequately visualised.
Study: NCT04169074

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abemaciclib
Description: Treatment will consist of a single neoadjuvant cycle of 10-21 days (+7 days). Abemaciclib will be administered from days 1-21. Abemaciclib may be continued for an additional 7 days, or up to 28 days, for delays in planned surgery.
Study: NCT06315738

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: ST266
Description: Patients randomized to investigative drug product (ST266) will receive either 0.5 mL/kg or 1.0 mL/kg of ST266 QD in addition to Standard of Care treatment; Patients randomized to SOC will receive standard of care treatment only.

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: ST266
Description: Patients randomized to investigative drug product (ST266) will receive either 0.5 mL/kg or 1.0 mL/kg of ST266 QD in addition to Standard of Care treatment; Patients randomized to SOC will receive standard of care treatment only.

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: ST266
Description: Patients randomized to investigative drug product (ST266) will receive either 0.5 mL/kg or 1.0 mL/kg of ST266 QD in addition to Standard of Care treatment; Patients randomized to SOC will receive standard of care treatment only.

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: ST266
Description: Patients randomized to investigative drug product (ST266) will receive either 0.5 mL/kg or 1.0 mL/kg of ST266 QD in addition to Standard of Care treatment; Patients randomized to SOC will receive standard of care treatment only.
Study: NCT06298201

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: E-Based Physical Exercise Intervention
Description: The intervention comprises a 6-months home-based resistance training for the lower extremities, conducted twice weekly.
Study: NCT04803955

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 16mg，KB
Description: 16mg,Q8h±3min,Day1-Day7

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: 16mg,Q8h±3min,Day1-Day7
Study: NCT06583915

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TENS
Description: Non-pharmacological method which is widely used by medical and paramedical professionals for the management of acute and chronic pain using electric pulse generator, lead wires and electrodes.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dry Needle
Description: Invasive procedure where a fine needle or acupuncture needle is inserted into the skin and muscle.
Study: NCT06426914

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Pilates
Description: Warmup: 5-10 minutes Pilates Clinical (Introductory program) The Hundred modified The Roll-up modified The roll-over modified Spine twist modified Single-leg circle modified Rolling like a ball Shoulder Bridge modified~For every Step emphasizing:~FOCUS: On muscle involved REPETITIONS: 3-5 VISUALIZATION: Imagination process (Different for each step) Cool down: 5 minutes Total Time: 30 minutes

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cardiac Rehabilitation
Description: Chest Physical therapy (Chest percussions and active huffs as per need) Breathing strategies (Diaphragmatic and purse lip 1-3 sets \* 5 Reps/Day)~Functional mobility (walk /cycling as per patient tolerance)~Patient education and Wound care Sternal Precaution guidance
Study: NCT05382897

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plant-based fasting-mimicking diet
Description: Participants will be on a low caloric plant-based diet or a caloric-sufficient plant-based diet for 3 x 5 day cycle each month followed by 3 weeks of eating normally for a total period of 3 months.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plant-based fasting-mimicking diet
Description: Participants will be on a low caloric plant-based diet or a caloric-sufficient plant-based diet for 3 x 5 day cycle each month followed by 3 weeks of eating normally for a total period of 3 months.
Study: NCT05014568

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tapinarof cream, 1%
Description: applied topically once daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle cream
Description: applied topically once daily
Study: NCT05044195

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: aQIV
Description: Participants receive a 0.5-mL intramuscular dose of aQIV on Day 1

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Comparator QIV
Description: Participants receive a 0.5-mL intramuscular dose of Comparator QIV on Day 1
Study: NCT06444178

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin
Description: Oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Oral administration
Study: NCT04822207

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: Patients undergo acupuncture at the beginning of embryo transfer cycle three times a week until 14 days after embryo transfer. Every acupuncture lasts 20 minutes.
Study: NCT04939415

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mQFPD
Description: The dosage of mQFPD is 8 capsules three times a day for 14 consecutive days. It does not need to be consumed with food. It is best taken at least 30 minutes before OR at least 60 minutes after meals, in the morning, noon and evening. Accidentally missed doses will not need to be taken at a later time but will be recorded in a daily diary.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: organic brown rice
Description: The dosage of mQFPD is 8 capsules three times a day for 14 consecutive days. It does not need to be consumed with food. It is best taken at least 30 minutes before OR at least 60 minutes after meals, in the morning, noon and evening. Accidentally missed doses will not need to be taken at a later time but will be recorded in a daily diary.
Study: NCT05986617

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: InBody Band 2
Description: Wearable bioimpediance monitor similar to a fitness watch.
Study: NCT04730427

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GX-I7
Description: Recombinant human interleukin-7 hybrid Fc

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: GX-I7 vehicle
Description: Formulation buffer of recombinant human interleukin-7 hybrid Fc
Study: NCT06146582

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Laguna Coach and App Intervention Group
Description: Behavioral, mental and contextual support was delivered through personal interactions with Laguna Coaches via mobile app, phone, video, or web chat. Care interventions were individualized to best match each participant's needs and strengths. Support will be provided to participants through interactions over approximately 90 days.
Study: NCT06522399

Intervention type: PROCEDURE
Intervention: TAMIS mucosectomy
Description: internal Delorme's procedure using TAMIS
Study: NCT04033601

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Non-pharmacological intervention
Description: The non-pharmacological intervention will comprise sleep hygiene education, exercise training and relevant modules of cognitive behavioral therapy.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Non-pharmacological intervention
Description: The non-pharmacological intervention will comprise sleep hygiene education, exercise training and relevant modules of cognitive behavioral therapy.
Study: NCT06218407

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) short burst paradigm
Description: The CBOT device is designed to stimulate intensive neural activity in the medial orbitofrontal regions over long periods of time.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) long burst paradigm
Description: The CBOT device is designed to stimulate intensive neural activity in the lateral orbitofrontal regions and networks over long periods of time.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Computerized Chemosensory-Based Orbitofrontal Cortex Training plus beta caryophyllene (CBOT-Plus)
Description: CBOT device enhanced with BCP.

Intervention type: COMBINATION_PRODUCT
Group type: SHAM_COMPARATOR
Intervention: Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT)
Description: CBOT device administering continuous olfactory stimuli (i.e., not programmed for short or long burst), and without BCP enhancement.
Study: NCT03463954

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Novilase Laser ablation
Description: Image-guided, percutaneous laser ablation of breast tumors
Study: NCT05346263

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Abdominal Pressure Ventilation
Description: Patients of experimental group will use IAPV in daytime ventilation. Intermittent abdominal pressure ventilation (IAPV) is a portable ventilator with an internal battery and PneumoBelt corset as an interface.
Study: NCT06079151

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nasal high-flow
Description: Nasal high-flow is a respiratory technique which allows the administration of warmed and humidified air, associated with oxygen if necessary

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nasal high-flow
Description: Nasal high-flow is a respiratory technique which allows the administration of warmed and humidified air, associated with oxygen if necessary
Study: NCT05821725

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Description: Hyaluronic acid and hemostatic sponge

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Hemostatic sponge
Study: NCT06464965

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CB CAR-NK182
Description: To study the maximum tolerated dose (MTD) and dose-dependent toxicity (DLT) of cord blood-derived CAR-NK cells (CB CAR-NK182) targeting Claudin18.2 in patients with advanced gastric cancer and advanced pancreatic cancer
Study: NCT06245538

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Seated rest
Description: Participants will be resting while seated on a comfortable chair for 20 minutes

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise at moderate intensity
Description: Participants will perform a 20-min leg cycling exercise on a cycle ergometer at moderate intensity (60% of VO2max)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise at vigorous intensity
Description: Participants will perform a 20-min leg cycling exercise on a cycle ergometer at vigorous intensity (80% of VO2max)
Study: NCT04989647

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: No adjuvant therapy
Description: Patients will not receive any type of adjuvant therapy.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy
Description: Patients will receive adjuvant treatment composed of either pelvic radiotherapy external beam radiotherapy ± brachytherapy or concomitant chemoradiotherapy (pelvic radiotherapy + chemotherapy).
Study: NCT05346263

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Usual ventilation
Description: NIV
Study: NCT05169060

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fish Oil Concentrate, 1000 Mg Oral Capsule
Description: Oral capsules, 2 grams or 4 grams per day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fish Oil Concentrate, 1000 Mg Oral Capsule
Description: Oral capsules, 2 grams or 4 grams per day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salsalate Oral Tablet
Description: Oral tablets, 1.5 gram or 3.0 gram per day.
Study: NCT04721548

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minoxidil Topical Foam
Description: Apply 1 mL of solution twice a day.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 mL of solution twice a day.
Study: NCT05106855

Intervention type: RADIATION
Group type: OTHER
Intervention: Low Laser Radiation
Description: One group will receive laser application to check if there is acceleration of healing.

Intervention type: RADIATION
Group type: OTHER
Intervention: Low Laser Radiation
Description: One group will receive laser application to check if there is acceleration of healing.

Intervention type: OTHER
Group type: OTHER
Intervention: Changing the implant surface
Description: Changing the treatment surface of the dental implant to see if osseointegration occurs more quickly.

Intervention type: OTHER
Group type: OTHER
Intervention: Changing the implant surface
Description: Changing the treatment surface of the dental implant to see if osseointegration occurs more quickly.

Intervention type: RADIATION
Group type: OTHER
Intervention: Low Laser Radiation off
Description: This group will receive laser application off.

Intervention type: RADIATION
Group type: OTHER
Intervention: Low Laser Radiation off
Description: This group will receive laser application off.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Implant placement immediately after tooth extraction
Description: When the last alternative is tooth extraction, this will be done, and in the same surgical intervention the dental implant will be placed.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Implant placement immediately after tooth extraction
Description: When the last alternative is tooth extraction, this will be done, and in the same surgical intervention the dental implant will be placed.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Implant placement immediately after tooth extraction
Description: When the last alternative is tooth extraction, this will be done, and in the same surgical intervention the dental implant will be placed.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Implant placement immediately after tooth extraction
Description: When the last alternative is tooth extraction, this will be done, and in the same surgical intervention the dental implant will be placed.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Installing the dental crown with early loading
Description: The installation of the dental crowns will be performed in a period of 6 to 8 weeks, after the dental implant has been installed.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Installing the dental crown with early loading
Description: The installation of the dental crowns will be performed in a period of 6 to 8 weeks, after the dental implant has been installed.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Installing the dental crown with early loading
Description: The installation of the dental crowns will be performed in a period of 6 to 8 weeks, after the dental implant has been installed.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Installing the dental crown with early loading
Description: The installation of the dental crowns will be performed in a period of 6 to 8 weeks, after the dental implant has been installed.
Study: NCT05951530

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: traditional physical therapy
Description: this group received conventional upper extremity active ROMs and stretches for 30 minutes three to five times a week for 6 weeks without using the app-based cognitive training.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mobile app-based cognitive training
Description: This group received mobile app-based cognitive training of 30minutes session three to five times a week for 6 weeks which includes a few activities such as the memory, coordination and alertness along with conventional UE exercises for 15 minutes three to five times a week for 6 weeks.
Study: NCT05272904

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Quilting
Description: Following mastectomy and/or axillary lymph node dissection, the subcutaneous tissue is sutured to the pectoralis muscle placing multiple rows of running sutures. The suture starts at either end of the scar, running back and forth, creating rows of quilting stiches. The rows are placed transversely from the cranial to the caudal end of the wound with 2-3 cm between them, totalling some three to ﬁve rows for the cranial ﬂap. The caudal ﬂap is quilted with 2-3 rows in a caudal to cranial fashion. A subcutaneous suture followed by a intracutaneous running suture is used to close the skin.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional wound closure
Description: Following mastectomy, skin is closed using subcutaneous sutures followed by intracutaneous running suture. Depending on the surgeons discretion a vacuum closed suction drain was placed beneath the skin flaps.
Study: NCT05473273

Intervention type: DRUG
Intervention: Endometrin 100Mg Vaginal Insert
Description: Endometrin will start once endometrial thickness is equal or higher to 7 mm with a trilaminar appearance, after at least 10 days and always less than 16 days of estradiol administration. First day of supplementation a dose of 100mg will be administered at of at 1.pm and 9 pm. From the second day and onwards administration will be increased to three times daily, at 6 am, 2 pm and 10 pm

Intervention type: DRUG
Intervention: Estradiol Valerate
Description: Estradiol valerate dose will be reduced to 4mg daily at 7 pm during the first two days of vaginal natural micronized progesterone supplementation and increased afterwards to 6 mg daily (2 mg at 10 am and 4 mg at 7 pm).
Study: NCT06278246

Intervention type: RADIATION
Intervention: PET Scan
Description: PET scan using the novel \[11C\]MK-6884 tracer to measure M4R during the antipsychotic-free state

Intervention type: RADIATION
Intervention: PET Scan
Description: PET scan using the novel \[11C\]MK-6884 tracer to measure M4R during the antipsychotic-free state
Study: NCT05793528

Intervention type: PROCEDURE
Intervention: Fluoroscopy Guided Transforaminal Epidural Steroid Injection
Description: The patients are positioned prone. The injection site is cleaned with povidone-iodine 3 times and a sterile drape was applied. Short-acting local anesthesia (3 mL of 2% prilocaine) is applied to the skin and subcutaneous tissue. A 3.5-inch, 22-gauge spinal needle is inserted just below the pedicle. It is advanced into the subpedicular space using the coaxial technique under the intermittent guidance of fluoroscopy. The needle position is confirmed through a lateral view. Using lateral views, the needle is placed at the posterior one-third of the foramen. Using the anteroposterior view, one to 2 mL of the contrast agent (300 mg/50 mL iohexol) is given and the distribution pattern is visualized. Once the epidural distribution of the contrast agent is confirmed without vascular flow, a mixture of 8 mg (two mL) of dexamethasone, 1 mL of physiological saline, and 1 mL (0.5%) of bupivacaine hydrochloride is injected.

Intervention type: PROCEDURE
Intervention: Ultrasound Guided Transforaminal Epidural Steroid Injection
Description: The patients are positioned prone placed. Following the provision of aseptic conditions, the spinous process of the vertebral midline is visualized using a low-frequency convex ultrasound probe. The lateral edge of the relevant vertebral lamina is visualized by sonographic scanning in the horizontal plane. Local anesthesia is applied to the skin and subcutaneous tissue. A 3.5-inch, 22-gauge spinal needle is advanced to the lateral edge of the relevant vertebral lamina under ultrasound image guidance. Then, anteroposterior imaging is performed with fluoroscopy to confirm needle localization when the lamina margin is reached, and the needle is guided into the foramen under the guidance of fluoroscopy. The contrast agent is given and the distribution pattern is visualized. Once the epidural distribution of the contrast agent is confirmed without vascular flow, a mixture of 2 mL of dexamethasone, 1 mL of physiological saline, and 1 mL (0.5%) of bupivacaine hydrochloride is injected.
Study: NCT06541288

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: AI Prediction Model
Description: Pelvic MRI was performed after pathologic diagnosis clarified the diagnosis of cervical cancer. Further pelvic lymph node metastasis status was determined by artificial intelligence multimodal fusion prediction modeling

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Imageing Assessment
Description: Pelvic MRI was performed after pathologic diagnosis clarified the diagnosis of cervical cancer.Further pelvic MRI images are read by a specialized imaging physician to determine pelvic lymph node status.